Faculty

Silvia de Sanjose Llongueras

Affiliate Professor, Epidemiology


Education

MD Medicine & Surgery, University of Barcelona, 1980
MSc Epidemiology, London School of Hygiene & Tropical Medicine (UK), 1986
PhD Epidemiology, London School of Hygiene & Tropical Medicine (UK), 1989

Contact


ISGlobal
Barcelona,

Bio

Dr. de Sanjose is a Medical Doctor from the University of Barcelona, Spain and PhD from the London University, UK. She is an epidemiologist working on HPV-related diseases for over 35 years. She has been employed at WHO- IARC, at the Catalan Institute of Oncology in Barcelona, Spain, at PATH in Seattle, and at the USA National Cancer Institute. She is the Past President of the International PapillomaVirus Society (2015-18). She is an associated researcher at ISGlobal in Barcelona, Spain and has a grant with Dr Margaret Madeline and Ann Durr from the Fred Hutch.

She is interested in the pathways of cervical cancer prevention and all HPV-related cancers through vaccination and secondary prevention and adequate management. She co-leads a Moonshoot-related project, the PAVE project, which primarily emphasizes the utilization of HPV detection through self-sampling, extended genotype information, and, for women who test positive for HPV, the automated evaluation of cervical images using AI-based solutions to enhance visual assessment with acetic acid. She is involved in shaping the World Health Organization's living guidelines for cervical cancer screening and the Code of Cancer Prevention for Europe.

Research Areas

Research Interests

I am interested in the pathways of cervical cancer prevention and all HPV-related cancers through vaccination and secondary prevention and adequate management. In particular I am involved in improving cervical cancer screening in poor resource settings.

Recent Publications (PubMed)

Effect of malaria parasitaemia on antibody responses to single-dose and two-dose HPV vaccination: results from the DoRIS dose-reduction immunogenicity trial in Tanzanian girls.
(2026 Jun 30)
Vaccine 89(): 128889
Whitworth HS, Beshir KB, Baisley KJ, Mbwanji G, Indangasi J, Kemp T, Kamala B, Maxwell C, Hashim R, Mukerebe C, Mayaud P, Lowe B, Gabriel N, Connor N, Kapiga S, De Sanjose S, Lacey CJ, Hayes RJ, Pinto L, Changalucha J, Sutherland CJ, Watson-Jones D

Natural history of anal HSIL and predictive value of cytology and HPV biomarkers in MSM living with HIV: A prospective cohort study.
(2026 Jun 9)
Int J Infect Dis 170(): 108872
Silva-Klug AC, Paytubi S, Trenti L, Sánchez-Llamas M, Baixeras N, Peón G, Tous S, Pavon MA, Torres M, De Sanjose S, Vega-Costa J, Vidal A, Alemany L, Podzamczer D, Saumoy M

European Code Against Cancer, 5th edition - cancer-causing infections and related interventions.
(2026 Jan)
Mol Oncol 20(1): 96-116
Alberts CJ, Bloem P, de Sanjosé S, Grabar S, Leja M, Malfertheiner P, Matičič M, Mégraud F, Negro F, Plummer M, Schim van der Loeff M, Balbín G, Salazar J, Zeeb H, Feliu A, D'Souza E, Ritchie D, Espina C, Franceschi S

Accelerating HPV-related cancer elimination - a meeting report.
(2025 Aug 29)
BMC Proc 19(Suppl 19): 22
Burdier FR, Bosch FX, Waheed DE, Teblick L, Poljak M, Baay M, de Sanjosé S, Bardou M, Baussano I, Man I, Franco EL, Vorsters A

Prevalence of, and factors associated with oral sexual behaviours in men and women in Ibadan, Nigeria.
(2025)
PLoS One 20(7): e0328454
Morhason-Bello IO, Daniel A, Adisa A, Baisley K, Adewole I, Bakare R, Murphy R, Hou L, de Sanjosé S, Francis SC, Watson-Jones D

Show complete publication list

In the News

No news articles at this time.